Paul L Bellamy - FDA Investigator Report

Overview Statistics

225
Total Inspections
32
Total 483s Issued
5
Warning Letters Issued

Inspection Details

Longest Inspection: 33 days
Shortest Inspection: 1 days
Average Length: 3.2 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Paul L Bellamy's Recent Inspections

DateCompanyCityCountryFEI Number483
2017-08-11Novitium Pharma LLCEast WindsorUnited States3012541241
2017-06-28SOFIE CoTotowaUnited States3008415560
2017-06-13Fersinsa Gb SA de CVRamos ArizpeMexico3000538793
2017-05-23Akorn Inc.CranburyUnited States3013036275
2017-05-12Akorn Inc.SomersetUnited States2246848
2017-04-26Renaissance Lakewood, LLCLakewoodUnited States2242829
2017-04-04Hikma Pharmaceuticals USA Inc.Cherry HillUnited States2220525
2017-03-20Amneal Pharmaceuticals, LLCPiscatawayUnited States3008861605
2017-02-23EMSL Analytical, Inc.CinnaminsonUnited States3003933331
2017-02-14Novel Laboratories, Inc. d.b.a Lupin SomersetSomersetUnited States3006271438

Sign Up to get the complete report.

Download 483s and EIRs for Paul L Bellamy

Paul L Bellamy - Co-Inspectors

Paul L Bellamy's Active Locations

  • United States
  • China
  • Mexico
  • Taiwan
  • India
  • France
  • Japan
  • Philippines
  • Israel
  • Portugal
  • United Kingdom
  • Australia
  • Singapore
  • Finland
  • Korea (the Republic of)
  • Poland
  • Austria
  • Norway
  • Jordan

Paul L Bellamy's Year-wise Inspection Count

  • 2008:32 inspections
  • 2009:22 inspections
  • 2010:21 inspections
  • 2011:22 inspections
  • 2012:20 inspections
  • 2013:24 inspections
  • 2014:29 inspections
  • 2015:21 inspections
  • 2016:22 inspections
  • 2017:12 inspections
Last Updated: 2025-05-14 06:11:22